UNSPSC 51284125: Cefditoren pivaloyloxymethyl ester

This classification denotes a cephalosporin antibiotic with the molecular formula C25H28N6O7S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 78THA212DH, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(((2z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-((1z)-2-(4-methyl-5-thiazolyl)ethenyl)-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (6r,7r)-, but more generally known as cefditoren pivaloyloxymethyl ester, which bears US NIH Compound Identifier 444006.

UNSPSC 51284125 Cefditoren pivaloyloxymethyl ester is a Commodity code representing a specific pharmaceutical active ingredient, yet recent state and local solicitations tagged with this code show minimal alignment with the nominal scope. The opportunities posted under this code include Naloxone and drug deactivation systems procurement, pharmacy benefit program requests for information, first-aid supply bidding, and multi-source generic pharmaceutical contracting — none of which directly involve cefditoren or its formulations. The mismatch suggests either miscoding in the sourcing system or use of this code as a catch-all placeholder for pharmaceutical acquisitions without precise NDC- or ingredient-level classification.

Issuing bodies posting opportunities cross-tagged with this code span county health departments (Seminole County, Florida), state health agencies (Texas HHS Commission), municipal procurement offices (City of Tampa), and cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving multiple states including Oregon). Recent activities include an IFB from Seminole County for 1,900 units of Naloxone annually with a July 26, 2026 response deadline, an RFI from Texas HHS posted April 3, 2026 exploring direct-to-manufacturer prescription programs, an IFB from Tampa for 169 line items of medical and first-aid supplies with an estimated contract value of $700,000 and a sheltered-market set-aside for certified Small Local Business Enterprises, and an RFP from MMCAP with a March 26, 2026 response deadline for generic multi-source pharmaceuticals and OTC products across multiple state and local jurisdictions. The Tampa procurement included a 5 percent bid discount for certified SLBEs not to exceed $10,000. Geographic activity centers on Florida, Texas, and Minnesota-led multistate cooperative purchasing, with limited indication of concentrated or repeat buying patterns under this specific code classification.